DDMAC News

Say so long to DDMAC as FDA's OPDP levels up - Medical Marketing and Media



Say so long to DDMAC as FDA's OPDP levels up 
Medical Marketing and Media
Under the restructure, DDMAC becomes the Office of Prescription Drug Promotion, a level-up that will mean more authority and resources for promotion oversight at the agency. OPDP continues to be led by Tom Abrams and includes a Division of Professional ...

 


DDMAC slaps Premarin patient testimonials, Acuvail journal ad - Medical Marketing and Media



Medical Marketing and Media
 
DDMAC slaps Premarin patient testimonials, Acuvail journal ad 
Medical Marketing and Media
Patient testimonial videos on the brand.com homepage for Premarin, an estrogen tablet manufactured by Wyeth (now Pfizer), overstated the drug's efficacy and minimized risks, while a journal ad for Allergan's Acuvail made unsubstantiated superiority ...

and more » 


Sepracor's 'boxing bed' ad hit with DDMAC untitled letter - Medical Marketing and Media



Sepracor's 'boxing bed' ad hit with DDMAC untitled letter 
Medical Marketing and Media
The Division of Drug Marketing, Advertising, and Communications (DDMAC) said the ad made misleading claims, suggesting that Lunesta is clinically superior to other medications in second-line use and that its mechanism of action (MOA) is more precise ...

 


Intuniv patient kit draws DDMAC untitled letter - Medical Marketing and Media



Medical Marketing and Media
 
Intuniv patient kit draws DDMAC untitled letter 
Medical Marketing and Media
In a June 22 untitled letter posted today, DDMAC asked Shire to stop giving out an Intuniv ?patient starter kit,? including a parent guide, titration guide and ADHD support guide as well as in-office brochures. The agency said materials, which feature ...

and more » 


Boniva print ad hyped efficacy, says DDMAC - Medical Marketing and Media



Medical Marketing and Media
 
Boniva print ad hyped efficacy, says DDMAC 
Medical Marketing and Media
A print ad for Genentech's Boniva overstated the osteoporosis drug's efficacy, said the FDA's Division of Drug Marketing, Advertising and Communication in an untitled letter. The agency took issue with the claim in the ad, which features Sally Field ...

and more » 


DDMAC pokes Allergan on eye drop direct mail - Medical Marketing and Media



Medical Marketing and Media
 
DDMAC pokes Allergan on eye drop direct mail 
Medical Marketing and Media
Allergan has a superiority complex when it comes to marketing its ophthalmic drops, as evidenced by a second DDMAC Untitled Letter posted online yesterday. This time, a direct mail piece targeting physicians made unsubstantiated superiority claims ...

and more » 


DDMAC slaps Alcon convention graphic - Medical Marketing and Media



Medical Marketing and Media
 
DDMAC slaps Alcon convention graphic 
Medical Marketing and Media
A convention graphic for Alcon's Travatan Z, an ophthalmic drop, broadened the product's indication and made unsubstantiated superiority claims, according to a Division of Drug Marketing, Advertising and Communications (DDMAC) Untitled Letter. Although ...

 


DDMAC cites fishy Cymbalta fibromyalgia ads - Medical Marketing and Media



Medical Marketing and Media
 
DDMAC cites fishy Cymbalta fibromyalgia ads 
Medical Marketing and Media
DDMAC also released several untitled letters issued in December. The division warned Bayer HealthCare over a live consumer-directed program for its Mirena IUD, saying it found no evidence that the contraceptive device helps improve couples' romantic ...

 


DDMAC slaps J&J journal ad, Pedinol mailer - Medical Marketing and Media



Medical Marketing and Media
 
DDMAC slaps J&J journal ad, Pedinol mailer 
Medical Marketing and Media
DDMAC also issued an August 20 warning letter to Pedinol Pharmacal for a professional direct mailer for its Nalfon NSAID. The mailer, said DDMAC, ?recommends or suggests a specific use for Nalfon that the drug has not been evaluated by the FDA for and ...

and more » 


DDMAC loses a letter but gains a new name and more prominence - Lexology



DDMAC loses a letter but gains a new name and more prominence 
Lexology
It's time to learn a new acronym. The Food and Drug Administration's (FDA's) Division of Drug Marketing, Advertising, and Communications (DDMAC) is now the newly-named Office of Prescription Drug Promotion, or OPDP. Elevation to an ?Office? status ...